Fundraising is to scale up... surely this is positive?4 Jun 2020 08:40
BACKGROUND TO AND REASONS FOR THE FUNDRAISING
Pursuant to the Fundraising, the Company proposes to raise up to £45 million (before expenses) to fund the rapid scale-up of the broader Affimer® diagnostic products opportunities including COVID-19 antigen rapid testing and accelerated expansion of the in-house Affimer® and pre|CISION™ cancer therapy pipeline.